Untangling the immunological implications of nadir on CD4+ cell recovery during suppressive highly active antiretroviral therapy

Clin Infect Dis. 2008 Jan 1;46(1):149-50. doi: 10.1086/524087.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiretroviral Therapy, Highly Active / adverse effects*
  • CD4 Lymphocyte Count*
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology*
  • HIV Infections / drug therapy*
  • HIV Infections / immunology*
  • Homeostasis
  • Humans